国内外肿瘤药学服务研究可视化比较分析

doi:10.3969/j.issn.2095-1264.2024.02.14

首页 > 过刊浏览>2024年第2期 >229-236. DOI:10.3969/j.issn.2095-1264.2024.02.14

国内外肿瘤药学服务研究可视化比较分析
DOI:
                        10.3969/j.issn.2095-1264.2024.02.14
                    
作者:
                        
                        
                    
作者单位:1.上海市老年医学中心/复旦大学附属中山医院闵行梅陇院区 药剂科，上海，201104;2.复旦大学附属中山医院 药剂科，上海，200032
作者简介:鲁国璋，男，主管药师，研究方向：医院药学。
通讯作者:沈艺，女，主管药师，研究方向：医院药学，临床药学。
中图分类号:R730
基金项目:

Comparative visualization analysis of oncology pharmacy services research at home and abroad

Author:

Affiliation:

1.Department of Pharmacy, Shanghai Geriatric Medical Center/Zhongshan Hospital, Fudan University Minhang Meilong, Shanghai, 201104, China;2.Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, 200032, China

Fund Project:

摘要

图/表

访问统计

参考文献

相似文献

引证文献

资源附件

文章评论

摘要:

目的了解国内外肿瘤药学领域研究前沿与热点，对国内外肿瘤药学服务模式进行比较研究，以期为国内肿瘤药学服务的发展提供参考。方法分别以“肿瘤药学”联合“药学服务”或“药师”为中文主题词，以“Oncology pharmacy”联合“Pharmacy services”“Pharmaceutical care”为英文主题词，检索2010—2022年中国知网（CNKI）、万方数据库、维普数据库（VIP）及Web of Science收录的相关文献，运用CiteSpace对筛选去重后的文献进行网络可视化分析。结果 2010—2020年国内外肿瘤药学服务研究皆呈现上升趋势，2020年后呈现下降趋势，相关研究领域及热点有重叠之处，而国内外肿瘤药学服务在具体研究内容上存在差异。结论与国外相比，国内肿瘤药学服务研究还存在不足之处，今后应拓展视角，加强与国际肿瘤药学界的交流与合作。

Abstract:

Objective To understand the research frontiers and hotspots in the field of oncology pharmacy and to conduct a comparative study of oncology pharmaceutical service models at home and abroad, so as to provide a reference for the future development of oncology pharmacy in China.Methods Searching related literature with the themes of "oncology pharmacy", "pharmacy service" and "pharmacist" in CNKI, Wanfang and VIP databases, and Web of Science from 2010 to 2022. CiteSpace was used to conduct network visualization analysis of the literature after screening and removing duplicates.Results Oncology pharmacy research at home and abroad is on the rise until 2020, after which there is a downward trend, with overlapping research areas and hotspots and differences in specific research content.Conclusion Compared with foreign countries, there are still deficiencies in the research of oncology pharmaceutical services in China. In the future, we should expand the perspective and strengthen the communication and cooperation with the international oncology pharmaceutical community.